Recently a 62-year-old man was found without fingerprints due to his use of Xeloda, a cancer medication. The drug seems to have caused a lot of peeling to his fingers, leaving the man without fingerprints.
This came to attention when the man, known as Mr. S, tried to travel to the U.S. Apparently, very few patients experience this side effect, but it is known to happen.
Implications - In today's society, many individuals take a particular interest in mysterious discoveries or unlikely scientific breakthroughs. Such events or occasions satisfy the craving amongst many consumers for the unknown and impossible. Companies and businesses that are able to provide consumers with products and services that mimic similar feelings and reactions will fare well in today's science and answer-seeking society of consumers.
Freaky Side Effects
Xeloda Cancer Drug Eliminates Fingerprints
Trend Themes
1. Mysterious Discoveries - Opportunity for companies to develop products and services that cater to consumers' desire for unknown and impossible experiences.
2. Unlikely Scientific Breakthroughs - Potential for businesses to capitalize on consumers' interest in unexpected scientific advancements and create innovative products or services.
3. Answer-seeking Society - Companies can tap into the market of consumers who crave answers and provide them with products or services that offer similar feelings and reactions.
Industry Implications
1. Pharmaceuticals - Disruptive innovation opportunity for pharmaceutical companies to develop drugs with unexpected side effects that could cater to consumers' fascination with mysteries and unique experiences.
2. Entertainment - Opportunity for the entertainment industry to create immersive experiences or content that captivate consumers' interest in unlikely scientific breakthroughs and mysteries.
3. Technology - Innovation opportunity for technology companies to develop cutting-edge solutions that help satisfy the needs of an answer-seeking society, such as advanced AI systems that provide insightful and instantaneous responses.